235 related articles for article (PubMed ID: 30888379)
1. Liposome-based probes for molecular imaging: from basic research to the bedside.
Xia Y; Xu C; Zhang X; Ning P; Wang Z; Tian J; Chen X
Nanoscale; 2019 Mar; 11(13):5822-5838. PubMed ID: 30888379
[TBL] [Abstract][Full Text] [Related]
2. Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery.
Lamichhane N; Udayakumar TS; D'Souza WD; Simone CB; Raghavan SR; Polf J; Mahmood J
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385755
[TBL] [Abstract][Full Text] [Related]
3. Multicomponent nanocrystals with anti-Stokes luminescence as contrast agents for modern imaging techniques.
Generalova AN; Chichkov BN; Khaydukov EV
Adv Colloid Interface Sci; 2017 Jul; 245():1-19. PubMed ID: 28499601
[TBL] [Abstract][Full Text] [Related]
4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
5. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
[TBL] [Abstract][Full Text] [Related]
6.
Janasik D; Krawczyk T
Chemistry; 2022 Jan; 28(5):e202102556. PubMed ID: 34705306
[TBL] [Abstract][Full Text] [Related]
7. PET/MRI: Emerging Clinical Applications in Oncology.
Fraum TJ; Fowler KJ; McConathy J
Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic liposome nanoparticles for cellular and tumour imaging.
Kamaly N; Miller AD
Int J Mol Sci; 2010 Apr; 11(4):1759-76. PubMed ID: 20480040
[TBL] [Abstract][Full Text] [Related]
9. Porphyrin-Based Nanomedicines for Cancer Treatment.
Xue X; Lindstrom A; Li Y
Bioconjug Chem; 2019 Jun; 30(6):1585-1603. PubMed ID: 31023011
[TBL] [Abstract][Full Text] [Related]
10. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
[TBL] [Abstract][Full Text] [Related]
11. The use and importance of liposomes in positron emission tomography.
Silindir M; Özer AY; Erdoğan S
Drug Deliv; 2012 Jan; 19(1):68-80. PubMed ID: 22211758
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
13. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
14. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications.
Zheng J; Perkins G; Kirilova A; Allen C; Jaffray DA
Invest Radiol; 2006 Mar; 41(3):339-48. PubMed ID: 16481918
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI and FDG PET fused images for evaluation of patients with cancer.
Domingues RC; Carneiro MP; Lopes FC; Domingues RC; da Fonseca LM; Gasparetto EL
AJR Am J Roentgenol; 2009 Apr; 192(4):1012-20. PubMed ID: 19304708
[TBL] [Abstract][Full Text] [Related]
16. Current Status of Hybrid PET/MRI in Oncologic Imaging.
Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R
AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894
[TBL] [Abstract][Full Text] [Related]
17. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology.
Zheng J; Allen C; Serra S; Vines D; Charron M; Jaffray DA
Contrast Media Mol Imaging; 2010; 5(3):147-54. PubMed ID: 20586032
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
[TBL] [Abstract][Full Text] [Related]
19. Liver metastases: Detection and staging.
Lincke T; Zech CJ
Eur J Radiol; 2017 Dec; 97():76-82. PubMed ID: 29153371
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
